Copyright
©2013 Baishideng Publishing Group Co.
World J Hepatol. Jun 27, 2013; 5(6): 332-335
Published online Jun 27, 2013. doi: 10.4254/wjh.v5.i6.332
Published online Jun 27, 2013. doi: 10.4254/wjh.v5.i6.332
Figure 1 Hepatitis C virus RNA and alanine aminotransferase levels according to duration of hepatitis C virus treatment and transcatheter arterial chemoembolization.
HCV: Hepatitis C virus; TACE: Transcatheter arterial chemoembolization; ALT: Alanine aminotransferase.
Figure 2 Computed tomography scan image.
A: Illustrating a hypervascular hepatocellular carcinoma lesion (arrow) in arterial phase pre-treatment with transcatheter arterial chemoembolization; B: Indicating treatment response with loss of vascularity of the lesion (arrow) in arterial phase following transcatheter arterial chemoembolization procedure treatment.
- Citation: Torres HA, Mahale P, Miller ED, Oo TH, Frenette C, Kaseb AO. Coadministration of telaprevir and transcatheter arterial chemoembolization in hepatitis C virus-associated hepatocellular carcinoma. World J Hepatol 2013; 5(6): 332-335
- URL: https://www.wjgnet.com/1948-5182/full/v5/i6/332.htm
- DOI: https://dx.doi.org/10.4254/wjh.v5.i6.332